Literature DB >> 28865551

Serum antimüllerian hormone levels are independently related to miscarriage rates after in vitro fertilization-embryo transfer.

Bruno Tarasconi1, Teddy Tadros2, Jean-Marc Ayoubi2, Stephanie Belloc2, Dominique de Ziegler2, Renato Fanchin3.   

Abstract

OBJECTIVE: To investigate whether serum antimüllerian hormone (AMH) levels are independently related to miscarriage rates after in vitro fertilization-embryo transfer (IVF-ET).
DESIGN: Cohort study.
SETTING: University-affiliated IVF-ET center. PATIENT(S): A total of 1,060 patients who attained a clinical pregnancy after IVF-ET. INTERVENTIONS(S): Centralized serum AMH measurements were performed within the 12 months before IVF-ET. Binary logistic regression was used to verify whether serum AMH levels were associated with the occurrence of a miscarriage independently from confounding factors, such as age and intensity of ovarian response to controlled ovarian stimulation assessed by the number of oocytes retrieved. MAIN OUTCOME MEASURE(S): Miscarriage rates. RESULT(S): In patients displaying reduced serum AMH levels, miscarriage rates were significantly increased independently from age and the number of oocytes retrieved. CONCLUSION(S): The present data indicate that serum AMH levels are independently associated with the occurrence of a miscarriage after IVF-ET.
Copyright © 2017. Published by Elsevier Inc.

Entities:  

Keywords:  Antimüllerian hormone; biomarkers; in vitro fertilization; miscarriage; oocyte quality

Mesh:

Substances:

Year:  2017        PMID: 28865551     DOI: 10.1016/j.fertnstert.2017.07.001

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  13 in total

1.  Antimüllerian hormone as a risk factor for miscarriage in naturally conceived pregnancies.

Authors:  Brianna M Lyttle Schumacher; Anne Marie Z Jukic; Anne Z Steiner
Journal:  Fertil Steril       Date:  2018-06-02       Impact factor: 7.329

Review 2.  Anti-müllerian hormone as a predictor for live birth among women undergoing IVF/ICSI in different age groups: an update of systematic review and meta-analysis.

Authors:  Ni-Jie Li; Qing-Yun Yao; Xiao-Qiong Yuan; Yong Huang; Yu-Feng Li
Journal:  Arch Gynecol Obstet       Date:  2022-07-30       Impact factor: 2.493

3.  Live Birth Rates in Women Under 38 Years Old with AMH Level < 1.2 ng/ml in the First In Vitro Fertilization + / - Intracytoplasmic Sperm Injection: Retrospective Study and Arguments for Care.

Authors:  Karine Morcel; Philippe Merviel; Diane Pertuisel; Pandora James; Sarah Bouée; Mathilde Le Guillou; Jean-Jacques Chabaud; Sylvie Roche; Hortense Drapier; Aurore Perrin; Damien Beauvillard
Journal:  Reprod Sci       Date:  2022-09-29       Impact factor: 2.924

4.  Does quantity equal quality?-A morphokinetic assessment of embryos obtained from young women with decreased ovarian response to controlled ovarian stimulation.

Authors:  Natali Schachter-Safrai; Yoav Kan-Tor; Gilad Karavani; Yuval Or; Yoel Shufaro; Iris Har-Vardi; Amnon Buxboim; Assaf Ben-Meir
Journal:  J Assist Reprod Genet       Date:  2021-02-26       Impact factor: 3.412

5.  Anti-müllerian Hormone During Natural Cycle Presents Significant Intra and Intercycle Variations When Measured With Fully Automated Assay.

Authors:  Laura Melado; Barbara Lawrenz; Junard Sibal; Emmanuel Abu; Carol Coughlan; Alfredo T Navarro; Human Mousavi Fatemi
Journal:  Front Endocrinol (Lausanne)       Date:  2018-11-27       Impact factor: 5.555

6.  Efficacy and Safety of gonadotropin-releasing hormone (GnRH) Agonists Triptorelin Acetate and Cetrorelix Acetate in Assisted Reproduction.

Authors:  Jingjing Jiang; Shanshan Gao; Jin Xu
Journal:  Med Sci Monit       Date:  2018-11-08

7.  Age-specific anti-Mullerian hormone (AMH) levels poorly affects cumulative live birth rate after intra-uterine insemination.

Authors:  Jessika Moreau; Nicolas Gatimel; Cynthia Simon; Clémentine Cohade; Florence Lesourd; Jean Parinaud; Roger Léandri
Journal:  Eur J Obstet Gynecol Reprod Biol X       Date:  2019-05-13

8.  Early pregnancy ultrasound measurements and prediction of first trimester pregnancy loss: A logistic model.

Authors:  Laura Detti; Ludwig Francillon; Mary E Christiansen; Irene Peregrin-Alvarez; Patricia J Goeske; Zoran Bursac; Robert A Roman
Journal:  Sci Rep       Date:  2020-01-31       Impact factor: 4.379

9.  The Clinical Value of 3D Ultrasonic Measurement of the Ratio of Gestational Sac Volume to Embryo Volume in IoT-Based Prediction of Pregnancy Outcome.

Authors:  Yong Wang; Tiantian Li; Lichun Zhang; Jing Li; Bo Zou; Bhupesh Kumar Singh
Journal:  J Healthc Eng       Date:  2021-08-24       Impact factor: 2.682

10.  GnRH Antagonist Protocol With Cessation of Cetrorelix on Trigger Day Improves Embryological Outcomes for Patients With Sufficient Ovarian Reserve.

Authors:  Huihui Xu; Shen Zhao; Xinxing Gao; Xian Wu; Lan Xia; Dan Zhang; Jian Li; Aijun Zhang; Bufang Xu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-10-14       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.